Conversely, MALAT1 binds to an RNA-binding protein, Hu antigen R (HuR), and interacts with the CD133 gene to downregulate CD133, thus suppressing the epithelial-to-mesenchymal transition (EMT) and migration activity of breast cancer cells [81]. The gene discussed is ELAVL1; the disease is breast carcinoma.